SCHEMBL24724935

SCHEMBL24724935

CCN1CCN(c2ccc(C(=O)C(C)C)nc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
PARP1 P09874 12/20 0.46
PARP2 Q9UGN5 5/20 0.45
PARP6 Q2NL67 4/20 0.45
PARP3 Q9Y6F1 4/20 0.45
TNKS O95271 1/20 0.45
KDM4E B2RXH2 1/20 0.44
GAA P10253 1/20 0.44
RAD52 P43351 1/20 0.44
GFER P55789 1/20 0.44
TIPARP Q7Z3E1 1/20 0.43
CHRNA7 P36544 1/20 0.43
KCNH2 Q12809 1/20 0.42
WNT3A P56704 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933096 0.88 PARP1 (0.43) PARP1PARP2PARP6PARP3TNKS
SCHEMBL27397948 0.81 PARP1 (0.58) MAPTSMN1; SMN2NPC1RAB9APARP1
SCHEMBL24932854 0.80 HRH3 (0.46) PARP1
SCHEMBL25990173 0.76 HDAC3 (0.44) SMN1; SMN2KDM4ERAD52MEN1KMT2A
SCHEMBL10256408 0.76 GAA (0.50) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25600497 0.75 HRH3 (0.45) KDM4E
SCHEMBL5254754 0.75 ALDH1A1 (0.58) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25630786 0.74 HRH3 (0.46) MAPTSMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL25721557 0.74 PARP1 (0.58) MAPTSMN1; SMN2NPC1RAB9APARP1
SCHEMBL6889419 0.73 GAA (0.54) MAPTSMN1; SMN2NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235699-A2 POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed